BioSig Technologies Inc. Company
BioSig aims to play a vital role in the field of bioelectronic medicine, based on the unique enabling technology and core competency in signal processing. Its initial focus is on heart disease and the fast-growing electrophysiology device market. BioSig has built an impressive scientific and business track record. In less than 10 years, BioSig has developed a first-of-its-kind technology, attracted significant investment, conducted pre-clinical studies with centers of excellence, signed a 10-year strategic agreement with Mayo Clinic, and developed a robust IP strategy.
Technology:
Diagnostics and consultation
Industry:
Diagnosis, consultation, beauty education
Headquarters:
Westport, USA
Founded Date:
01.01.2009
Employees Number:
11-50
Funding Status:
IPO
Total Funding:
$90 978 163
Estimated Revenue:
$50-100 Mn
Last Funding Date:
24.06.2020
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership